Commonwealth Equity Services »

Candel Therapeutics shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $22k 14k 1.55

More positions owned by Commonwealth Equity Services

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Index Fds Value Etf (VTV)

View all positions for Commonwealth Equity Services

Top funds holding Candel Therapeutics

Northpond Ventures
Sands Capital Ventures
Vanguard Group
Geode Capital Management
Bridgeway Capital Management
Baystate Wealth Management
BlackRock
Mariner Wealth Advisors
Resources Investment Advisors
Northern Trust
Commonwealth Equity Services
Two Sigma Investments
Tower Research Capital
Jpmorgan Chase & Co
Wells Fargo & Company

View all funds holding Candel Therapeutics